Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102383 · ClinicalTrials.gov registry record · NA
Evaluation of Wear Experience With a Water Surface Daily Disposable Contact Lens
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05102383: Completed NA study, sponsored by Ohio State University.
NCT05102383 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102383, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the wear experience of existing wearers of a monthly replacement contact lens after they have been fit with a daily disposable contact lens that has water surface treatment.
Primary Outcome
Participants will complete a Visual Analog Scale survey of overall comfort (0-100 Scale with 0 anchored with "Poor Comfort" and 100 anchored as "Excellent Comfort")
Interventions
- DEVICE Comfilcon A Toric contact lenses
- DEVICE Verofilcon A for Astigmatism Daily Disposable contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-04-19 |
| Phase | NA |
What the finished NCT05102383 record still lists
NCT05102383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Comfilcon A Toric contact lenses is the first listed.
NCT05102383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102383 about?
NCT05102383 is a clinical study titled "Evaluation of Wear Experience With a Water Surface Daily Disposable Contact Lens". The purpose of this study is to assess the wear experience of existing wearers of a monthly replacement contact lens after they have been fit with a daily disposable contact lens that has water surface treatment.
What is the current status of trial NCT05102383?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-11-15. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT05102383?
The interventions under investigation include: Comfilcon A Toric contact lenses (DEVICE), Verofilcon A for Astigmatism Daily Disposable contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05102383?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05102383's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI